The DOI matches its Crossref record.
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 66
- Cogliano, 2005, Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment, Lancet Oncol, 6, 552, 10.1016/S1470-2045(05)70273-4 · DOI · Paper page
- Smith, 2003, Cervical cancer and use of hormonal contraceptives: a systematic review, Lancet, 361, 1159, 10.1016/S0140-6736(03)12949-2 · DOI · Paper page
- 2006, Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13 541 women with carcinoma of the cervix and 23 017 women without carcinoma of the cervix from 23 epidemiological studies, Int J Cancer, 118, 1481, 10.1002/ijc.21493 · DOI · Paper page
- 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16 563 women with cervical cancer and 33 542 women without cervical cancer from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002/ijc.21953 · DOI · Paper page
- 2007, Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies, Int J Cancer, 120, 885, 10.1002/ijc.22357 · DOI · Paper page
- Ngelangel, 1998, Causes of cervical cancer in the Philippines: a case-control study, J Natl Cancer Inst, 90, 43, 10.1093/jnci/90.1.43 · DOI · Paper page
- Chichareon, 1998, Risk factors for cervical cancer in Thailand: a case-control study, J Natl Cancer Inst, 90, 50, 10.1093/jnci/90.1.50 · DOI · Paper page
- Sitas, 2000, The spectrum of HIV-1 related cancers in South Africa, Int J Cancer, 88, 489, 10.1002/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q · DOI · Paper page
- Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641 · DOI · Paper page
- 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016/S0140-6736(03)14065-2 · DOI · Paper page
- Zondervan, 1996, Oral contraceptives and cervical cancer—further findings from the Oxford Family Planning Association contraceptive study, Br J Cancer, 73, 1291, 10.1038/bjc.1996.247 · doi:10.1038/bjc.1996.247
- Plummer, 2004, Improved estimates of floating absolute risk, Stat Med, 23, 93, 10.1002/sim.1485 · DOI · Paper page
- Kjaer, 1996, Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia, Int J Cancer, 65, 601, 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6 · DOI · Paper page
- Hildesheim, 2001, HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica, Br J Cancer, 84, 1219, 10.1054/bjoc.2001.1779 · DOI · Paper page
- Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 · DOI · Paper page
- Schiffman, 1993, Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia, J Natl Cancer Inst, 85, 958, 10.1093/jnci/85.12.958 · DOI · Paper page
- Beral, 1988, Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study, Lancet, 2, 1331, 10.1016/S0140-6736(88)90869-0 · DOI · Paper page
- Ylitalo, 1999, Smoking and oral contraceptives as risk factors for cervical carcinoma in situ, Int J Cancer, 81, 357, 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1 · DOI
- Gram, 1992, Oral contraceptive use and the incidence of cervical intraepithelial neoplasia, Am J Obstet Gynecol, 167, 40, 10.1016/S0002-9378(11)91622-6 · doi:10.1016/s0002-9378(11)91622-6
- Brinton, 1986, Long-term use of oral contraceptives and risk of invasive cervical cancer, Int J Cancer, 38, 399, 10.1002/ijc.2910380307 · doi:10.1002/ijc.2910380307
- Jones, 1990, Risk factors for in situ cervical cancer: results from a case-control study, Cancer Res, 50, 3657
- Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541
- Madeleine, 2001, Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix, Cancer Epidemiol Biomarkers Prev, 10, 171
- Bosch, 1992, Risk factors for cervical cancer in Colombia and Spain, Int J Cancer, 52, 750, 10.1002/ijc.2910520514 · DOI · Paper page
- Cuzick, 1990, Case-control study of risk factors for cervical intraepithelial neoplasia in young women, Eur J Cancer, 26, 684, 10.1016/0277-5379(90)90117-C · DOI
- Ursin, 1994, Oral contraceptive use and adenocarcinoma of cervix, Lancet, 344, 1390, 10.1016/S0140-6736(94)90567-3 · DOI
- Ursin, 1996, Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States), Cancer Causes Control, 7, 391, 10.1007/BF00052946 · doi:10.1007/bf00052946
- Peters, 1986, Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County, J Natl Cancer Inst, 77, 1063
- Kjaer, 1993, Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use, Cancer Causes Control, 4, 513, 10.1007/BF00052426 · doi:10.1007/bf00052426
- Cuzick, 1996, Risk factors for invasive cervix cancer in young women, Eur J Cancer, 32A, 836, 10.1016/0959-8049(95)00650-8 · DOI
- Green, 2003, Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case-Control study of Cervical Cancer, Br J Cancer, 89, 2078, 10.1038/sj.bjc.6601296 · DOI
- Lacey, 1999, Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas, Cancer Epidemiol Biomarkers Prev, 8, 1079
- Thomas, 2001, Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas, Am J Epidemiol, 153, 732, 10.1093/aje/153.8.732 · DOI
- Brinton, 1990, Oral contraceptive use and risk of invasive cervical cancer, Int J Epidemiol, 19, 4, 10.1093/ije/19.1.4 · DOI
- Herrero, 1990, Injectable contraceptives and risk of invasive cervical cancer: evidence of an association, Int J Cancer, 46, 5, 10.1002/ijc.2910460103 · doi:10.1002/ijc.2910460103
- Hammouda, 2005, Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors, Int J Cancer, 113, 483, 10.1002/ijc.20600 · DOI
- Eluf-Neto, 1994, Human papillomavirus and invasive cervical cancer in Brazil, Br J Cancer, 69, 114, 10.1038/bjc.1994.18 · DOI · Paper page
- Santos, 2001, HPV types and cofactors causing cervical cancer in Peru, Br J Cancer, 85, 966, 10.1054/bjoc.2001.1948 · DOI
- Munoz, 1993, Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia, Cancer Epidemiol Biomarkers Prev, 2, 423
- Chaouki, 1998, The viral origin of cervical cancer in Rabat, Morocco, Int J Cancer, 75, 546, 10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T · DOI
- Rolón, 2000, Human papillomavirus infection and invasive cervical cancer in Paraguay, Int J Cancer, 85, 486, 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S · DOI
- Bayo, 2002, Risk factors of invasive cervical cancer in Mali, Int J Epidemiol, 31, 202, 10.1093/ije/31.1.202 · DOI · Paper page
- Franceschi, 2003, Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study, Int J Cancer, 107, 127, 10.1002/ijc.11350 · DOI · Paper page
- Parazzini, 1998, Time since last use of oral contraceptives and risk of invasive cervical cancer, Eur J Cancer, 34, 884, 10.1016/S0959-8049(97)10139-3 · doi:10.1016/s0959-8049(97)10139-3
- Parazzini, 1988, Risk factors for adenocarcinoma of the cervix: a case-control study, Br J Cancer, 57, 201, 10.1038/bjc.1988.43 · DOI
- Parazzini, 1992, Risk factors for cervical intraepithelial neoplasia, Cancer, 69, 2276, 10.1002/1097-0142(19920501)69:9<2276::AID-CNCR2820690912>3.0.CO;2-Q · doi:10.1002/1097-0142(19920501)69:9<2276::aid-cncr2820690912>3.0.co;2-q
- 1992, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 45, 299, 10.1016/0010-7824(92)90052-U · DOI
- 1993, Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Cancer, 55, 228, 10.1002/ijc.2910550211 · doi:10.1002/ijc.2910550211
- Ye, 1995, Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Epidemiol, 24, 19, 10.1093/ije/24.1.19 · doi:10.1093/ije/24.1.19
- Thomas, 1995, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 52, 307, 10.1016/0010-7824(95)00215-V · DOI
- Thomas, 1995, Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 51, 25, 10.1016/0010-7824(94)00007-J · DOI
- Thomas, 1996, Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, Am J Epidemiol, 144, 281, 10.1093/oxfordjournals.aje.a008923 · doi:10.1093/oxfordjournals.aje.a008923
- Boyce, 1977, Oral contraceptives and cervical carcinoma, Am J Obstet Gynecol, 128, 761, 10.1016/0002-9378(77)90717-7 · doi:10.1016/0002-9378(77)90717-7
- Celentano, 1987, The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study, Am J Epidemiol, 126, 592, 10.1093/oxfordjournals.aje.a114699 · DOI
- Ebeling, 1987, Use of oral contraceptives and risk of invasive cervical cancer in previously screened women, Intl J Cancer, 39, 427, 10.1002/ijc.2910390402 · doi:10.1002/ijc.2910390402
- Hsieh, 1999, Reproductive and infectious risk factors for invasive cervical cancer in Taiwan, Anticancer Res, 19, 4495
- Irwin, 1988, Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?, JAMA, 259, 59, 10.1001/jama.1988.03720010037037 · doi:10.1001/jama.1988.03720010037037
- Lazcano-Ponce, 1995, Reproductive risk factors and sexual history associated with cervical cancer in Mexico, Revista de Investigacion Clinica, 47, 377
- Melamed, 1969, Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids, BMJ, 3, 195, 10.1136/bmj.3.5664.195 · doi:10.1136/bmj.3.5664.195
- Slattery, 1989, Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis, Am J Epidemiol, 130, 248, 10.1093/oxfordjournals.aje.a115331 · DOI
- Talbott, 1995, Refining preventive strategies for invasive cervical cancer: a population-based case-control study, J Women's Health, 4, 387, 10.1089/jwh.1995.4.387 · doi:10.1089/jwh.1995.4.387
- Worth, 1972, A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix, J Obstet Gynaecol Br Commonw, 79, 673, 10.1111/j.1471-0528.1972.tb12899.x · doi:10.1111/j.1471-0528.1972.tb12899.x
- Shapiro, 2003, Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa), Cancer Causes Control, 14, 485, 10.1023/A:1024910808307 · DOI
- 1996, Breast cancer and hormonal contraceptives: further results, Contraception, 54, 13S
- Schiffman, 2003, Natural history of anogenital human papillomavirus infection and neoplasia, J Natl Cancer Inst Monogr, 31, 14, 10.1093/oxfordjournals.jncimonographs.a003476 · DOI · Paper page
- Yang, 2004, Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost, Int J Cancer, 109, 418, 10.1002/ijc.11719 · DOI · Paper page
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
HPV Vaccination and the Risk of Invasive Cervical Cancer
Lei, J., Ploner, A., Elfström, K. M., Wang, J., Roth, A., Fang, F., Sundström, K., Dillner, J., & Sparén, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917338 · Cited by 1,487
Cancer statistics for adolescents and young adults, 2020
Miller, K. D., Fidler‐Benaoudia, M., Keegan, T. H., Hipp, H. S., Jemal, A., & Siegel, R. L. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21637 · Cited by 1,190
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 370
- Issue
- 9599
- Pages
- 1609-1621
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1664871341
- Cited by
- 575
- References
- 0
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. https://app.cochat.ai/papers/10.1016/s0140-6736(07)61684-5
- The paper
- Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. (2007). The Lancet. https://doi.org/10.1016/s0140-6736(07)61684-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.